Quarterly report pursuant to Section 13 or 15(d)

Organization and Description of Business (Details Narrative)

v3.21.2
Organization and Description of Business (Details Narrative) - $ / shares
6 Months Ended
Apr. 16, 2021
Apr. 16, 2021
Jun. 30, 2021
Entity Listings [Line Items]      
Stock Issued During Period, Shares, Acquisitions     8,335,627
Asset Purchase Agreement [Member] | Supera Pharmaceuticals Inc [Member]      
Entity Listings [Line Items]      
Stock Issued During Period, Shares, Acquisitions   33,937,909  
MyMD Pharmaceuticals (Florida), Inc [Member]      
Entity Listings [Line Items]      
Common Stock, Par or Stated Value Per Share $ 0.001 $ 0.001  
Exchange ratio price per shares $ 0.7718 $ 0.7718  
Stockholders' Equity, Reverse Stock Split 1-for-2 reverse stock split    
Stock Issued During Period, Shares, Acquisitions 32,741,622